Radecke S, Schwarz K, Radecke F.
Mol Ther. 2018 Jan 3;26(1):115-131.
Radecke S, Schwarz K, Radecke F.
Mol Ther. 2018 Jan 3;26(1):115-131.
Oligonucleotide Therapeutics Society
c/o Event Innovations, Inc.
4377 Newport Avenue
San Diego, CA 92107, USA
info@oligotherapeutics.org
© Copyright 2012 – 2023 | Oligotherapeutics.org | All Rights Reserved | Finfrock Marketing